Data Insights
Q4 2023 update: private equity deals in pharmaceutical in Europe
In the European pharmaceutical industry, there were 21 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in the US
In the US pharmaceutical industry, there were 210 M&A deals announced in Q4 2023, worth a total value of $64.6bn,...
Q4 2023 update: private equity deals in pharmaceutical in India
In the Indian pharmaceutical industry, there were 3 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: private equity deals in pharmaceutical in Asia-Pacific
In the Asia-Pacific pharmaceutical industry, there were 10 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in North America
In the North American pharmaceutical industry, there were 228 M&A deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in Asia-Pacific
In the Asia-Pacific pharmaceutical industry, there were 104 M&A deals announced in Q4 2023, worth a total value of $16.1bn,...
How did Private equity deals perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 66 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in Europe
In the European pharmaceutical industry, there were 87 M&A deals announced in Q4 2023, worth a total value of $9.2bn,...
Q4 2023 update: M&A activity in pharmaceutical in the UK
In the British pharmaceutical industry, there were 33 M&A deals announced in Q4 2023, worth a total value of $779.7m,...
Q4 2023 update: private equity deals in pharmaceutical in North America
In the North American pharmaceutical industry, there were 34 private equity deals announced in Q4 2023, worth a total value...
Q4 2023 update: M&A activity in pharmaceutical in Japan
In the Japanese pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $1.5bn,...
Q4 2023 update: M&A activity in pharmaceutical in South and Central America
In the South and Central America pharmaceutical industry, there were 5 M&A deals announced in Q4 2023, worth a total...
Q4 2023 update: private equity deals in pharmaceutical in the US
In the US pharmaceutical industry, there were 31 private equity deals announced in Q4 2023, worth a total value of...
Q4 2023 update: M&A activity in pharmaceutical in Middle East and Africa
In the Middle East and Africa pharmaceutical industry, there were 7 M&A deals announced in Q4 2023, worth a total...
Q4 2023 update: M&A activity in pharmaceutical in India
In the Indian pharmaceutical industry, there were 19 M&A deals announced in Q4 2023, worth a total value of $7.4bn,...
How did M&A perform in pharmaceutical in Q4 2023?
In the global pharmaceutical industry, there were 426 M&A deals announced in Q4 2023, worth a total value of $84.2bn,...
Q4 2023 update: COVID-19 related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that COVID-19 accounted for 2 pharmaceutical deals announced in Q4 2023,...
Q4 2023 update: orphan designated drugs related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that orphan designated drugs accounted for 5 pharmaceutical deals...
Q4 2023 update: orphan designated drugs related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that orphan designated drugs accounted for 30 pharmaceutical deals announced in...
Q4 2023 update: M&A activity in pharmaceutical in China
In the Chinese pharmaceutical industry, there were 29 M&A deals announced in Q4 2023, worth a total value of $3.5bn,...